Edition:
United States

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.24USD
4:00pm EDT
Change (% chg)

$0.01 (+0.81%)
Prev Close
$1.23
Open
$1.22
Day's High
$1.25
Day's Low
$1.22
Volume
6,314
Avg. Vol
109,457
52-wk High
$2.65
52-wk Low
$0.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.191
Dec 0.00 -0.250
Sep 0.00 -0.531
Jun 0.00 -0.278
FY 2017 Mar '17 0.00 -0.325
Dec 1.25 -0.343
Sep 0.00 -0.416
Jun 0.00 -0.514
FY 2016 Mar '16 0.00 -4.445
Dec 0.00 -1.952
Sep 0.00 -5.263
Jun 0.00 -19.233
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Mar-19 1 0.00 0.00 0.00 0.00
Year Ending Mar-20 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 1 -0.14 -0.14 -0.14 -0.23
Quarter Ending Mar-18 2 -0.41 -0.28 -0.55 --
Year Ending Mar-18 2 -1.58 -1.08 -2.08 --
Year Ending Mar-19 1 -0.56 -0.56 -0.56 -0.90
Year Ending Mar-20 1 -0.59 -0.59 -0.59 -0.86
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.54 30.58
P/E High - Last 5 Yrs. -- 42.02 47.03
P/E Low - Last 5 Yrs. -- 23.71 24.81
Beta -0.83 0.86 0.85
Price to Sales (TTM) -- 3.59 8.15
Price to Book (MRQ) -- 3.41 3.78
Price to Tangible Book (MRQ) 9.28 4.90 5.88
Price to Cash Flow (TTM) -- 19.97 21.39
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.93 1.79
Dividend Yield - 5 Year Avg -- 1.54 1.46
Dividend 5 Year Growth Rate -- -9.11 -6.23
Payout Ratio(TTM) -- 49.56 46.83

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.30 6.92
Sales (TTM) vs TTM 1 Yr. Ago -100.00 10.08 11.36
Sales - 5 Yr. Growth Rate -- 6.98 7.60
EPS (MRQ) vs Qtr. 1 Yr. Ago 29.80 13.37 18.25
EPS (TTM) vs TTM 1 Yr. Ago 14.30 -- --
EPS - 5 Yr. Growth Rate -- 6.42 7.55
Capital Spending - 5 Yr. Growth Rate -58.84 7.23 7.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.57 2.53
Current Ratio (MRQ) 4.19 3.63 3.58
LT Debt to Equity (MRQ) 0.27 8.85 11.26
Total Debt to Equity (MRQ) 5.97 11.63 14.56
Interest Coverage (TTM) -1,883.16 36.02 31.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.52 55.12
Gross Margin - 5 Yr. Avg. -- 53.24 53.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -4,304.12 18.74 15.77
Operating Margin (TTM) -- 14.38 -2.60
Operating Margin - 5 Yr. Avg. -6,666.20 14.37 10.94
Pre-Tax Margin (TTM) -- 14.67 -0.67
Pre-Tax Margin - 5 Yr. Avg. -7,093.06 14.60 11.11
Net Profit Margin (TTM) -- 11.29 -3.89
Net Profit Margin - 5 Yr. Avg. -7,094.03 10.92 7.47
Effective Tax Rate (TTM) -- 20.50 20.48
Effective Tax Rate - 5 Yr. Avg. -- 23.83 24.17

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 842,714,883 735,010,332
Net Income/Employee (TTM) -1,810,567 98,299,820 85,647,511
Receivable Turnover (TTM) -- 5.50 5.48
Inventory Turnover (TTM) -- 2.49 3.59
Asset Turnover (TTM) 0.00 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -304.80 10.52 10.23
Return on Assets - 5 Yr. Avg. -783.68 11.51 11.03
Return on Investment (TTM) -416.96 13.15 12.84
Return on Investment - 5 Yr. Avg. -- 14.93 14.24
Return on Equity (TTM) -1,346.50 15.15 15.02
Return on Equity - 5 Yr. Avg. -- 16.18 15.57
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 27.34 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for VistaGen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.04%
# of Holders: 23
Total Shares Held: 3,278,427
3 Mo. Net Change: 172,952
# New Positions: 5
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 3
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.